Nucleus RadioPharma

nucleusrad.com

Nucleus Radio Pharma is a full-service contract development and manufacturing organization (CDMO) focused on targeted radiotherapies. The company aims to build robust clinical and commercial supply chains for radiopharmaceuticals, leveraging their extensive experience in manufacturing and supply chain management. With a national manufacturing footprint and a facility in Rochester, MN, set to begin production in Q4 2024, Nucleus Radio Pharma is positioned to address the bottlenecks in the market and accelerate the path to commercialization for innovative cancer treatments. Their singular focus on client success differentiates them from other CDMOs, making them a reliable partner for biotech and pharmaceutical companies.